Kapitalo Investimentos Ltda Sells 688 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Kapitalo Investimentos Ltda cut its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 76.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 212 shares of the medical device company’s stock after selling 688 shares during the period. Kapitalo Investimentos Ltda’s holdings in Cooper Companies were worth $80,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of COO. Norges Bank bought a new position in Cooper Companies in the fourth quarter worth $196,045,000. Victory Capital Management Inc. lifted its holdings in shares of Cooper Companies by 16.5% during the 4th quarter. Victory Capital Management Inc. now owns 995,245 shares of the medical device company’s stock worth $376,641,000 after acquiring an additional 140,700 shares during the period. International Assets Investment Management LLC acquired a new stake in shares of Cooper Companies during the 4th quarter valued at about $44,397,000. Ameriprise Financial Inc. increased its stake in Cooper Companies by 47.0% in the third quarter. Ameriprise Financial Inc. now owns 354,909 shares of the medical device company’s stock valued at $112,865,000 after acquiring an additional 113,395 shares during the period. Finally, Point72 Asset Management L.P. raised its position in Cooper Companies by 65.3% in the fourth quarter. Point72 Asset Management L.P. now owns 240,317 shares of the medical device company’s stock worth $90,946,000 after purchasing an additional 94,906 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

COO opened at $91.73 on Friday. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.14. The stock has a market capitalization of $18.27 billion, a P/E ratio of 53.88, a price-to-earnings-growth ratio of 2.27 and a beta of 1.02. The company’s 50 day simple moving average is $93.08 and its 200-day simple moving average is $94.58. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $104.07.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.02. The firm had revenue of $942.60 million for the quarter, compared to analyst estimates of $948.07 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the company earned $0.77 EPS. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.57 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on COO. Robert W. Baird lifted their price objective on Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a report on Friday, May 31st. Citigroup increased their price objective on Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Stifel Nicolaus restated a “buy” rating and issued a $110.00 target price (up previously from $105.00) on shares of Cooper Companies in a research note on Friday, March 1st. Mizuho increased their target price on shares of Cooper Companies from $102.50 to $115.00 and gave the stock a “buy” rating in a research report on Friday, March 1st. Finally, Piper Sandler lifted their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Friday, March 1st. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $111.42.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.